anidulafungin has been researched along with Opportunistic Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuenca-Estrella, M; Gurguí, M | 1 |
| Espinel-Ingroff, A | 1 |
| Chiou, CC; Groll, AH; Walsh, TJ | 1 |
| Bacher, JS; Groll, AH; Lyman, CA; Mickiene, D; Petraitiene, R; Petraitis, V; Piscitelli, SC; Walsh, TJ | 1 |
2 review(s) available for anidulafungin and Opportunistic Infections
| Article | Year |
|---|---|
[Current status of invasive fungal infections. New diagnostic techniques and antifungal agents].
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; beta-Glucans; Candidiasis; Clinical Trials as Topic; Critical Care; Diabetes Complications; Disease Susceptibility; Echinocandins; Fungemia; Galactose; Hematologic Diseases; Humans; Immunocompromised Host; Mannans; Meta-Analysis as Topic; Mycoses; Neoplasms; Opportunistic Infections | 2008 |
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.
Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2000 |
2 other study(ies) available for anidulafungin and Opportunistic Infections
| Article | Year |
|---|---|
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Culture Media; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Structure-Activity Relationship; Triazoles; Yeasts | 1998 |
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling.
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Echinocandins; Female; Lung Diseases, Fungal; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Rabbits; Tissue Distribution | 2001 |